Gyre Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -214.0% | -214.0% | -158.0% |
| FY2022 | 10.1% | 10.1% | 5.1% |
| FY2023 | 540.1% | 540.1% | -73.3% |
| FY2024 | 28.3% | 28.3% | 14.3% |
| FY2025 | 9.3% | 9.3% | 5.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -214.0% | -214.0% | -158.0% |
| FY2022 | 10.1% | 10.1% | 5.1% |
| FY2023 | 540.1% | 540.1% | -73.3% |
| FY2024 | 28.3% | 28.3% | 14.3% |
| FY2025 | 9.3% | 9.3% | 5.9% |